Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: GRI Bio Inc., 3 years.
GRI Bio Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
GRI Bio Inc. July 7, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 13, 2023 | Heron Therapeutics Inc. | Option exercise | +1,250 | — | — |
| Jul 13, 2023 | Heron Therapeutics Inc. | Option exercise | +4,564 | — | — |
| Jul 13, 2023 | Heron Therapeutics Inc. | Shares withheld for tax | −2,012 | $1.31 | $2,636 |
| Apr 13, 2023 | Heron Therapeutics Inc. | Option exercise | +1,250 | — | — |
| Apr 13, 2023 | Heron Therapeutics Inc. | Option exercise | +4,564 | — | — |
| Apr 13, 2023 | Heron Therapeutics Inc. | Shares withheld for tax | −2,012 | $2.88 | $5,795 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.